1. Boenisch U, Bohme A, Kohajda T, Mögel I, Schütze N, von Bergen M, Simon JC, Lehmann I, Polte T (2012) Volatile organic compounds enhance allergic airway inflammation in an experimental mouse model. PLoS One 7(7):e39817, 1–14. ( http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0039817 )
2. Jouyban A, Fakhree MA, Shayanfar A (2010) Review of pharmaceutical applications of N-methyl-2-pyrrolidone. J Pharm Pharm Sci 13(4):524–535. ( https://ejournals.library.ualberta.ca/index.php/JPPS/article/download/8257/7452 )
3. Scientific Committee on Consumer Safety (SCCS) (2011) Opinion on N-Methyl-2-pyrrolidone. SCCS/1413/11,1-40 (Hrsg). European Commission Health & Consumers, Directorate D: Health Systems and Products, Unit D3 – Risk Assessment, European Union, Brussels, Belgium. http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_050.pdf
4. Ad-hoc -AG des Umweltbundesamtes (2014) Richtwerte für 1-Methyl-2-pyrrolidon in der Innenraumluft. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 57(10):1232–1241. ( http://link.springer.com/article/10.1007/s00103-014-2041-1 )
5. Deutsche Forschungsgemeinschaft (DFG) (1994) N-Methyl-2-pyrrolidon (Dampf). Gesundheitsschädliche Arbeitsstoffe. Toxikologisch-arbeitsmedizinische Begründungen von MAK-Werten, 20. Lieferung. Wiley-VCH, Weinheim, S 1–2